Year archive

Nirvana Life Sciences Inc — 2020 filings

All 17 regulatory filings released by Nirvana Life Sciences Inc (NIRV) in 2020, sourced directly from the official regulator.

17 Filings

2020 Period

2020 filings (17)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2020-09-25	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2020-09-25	English
Interim MD&A - English.pdf Regulatory Filings	2020-09-25	English
Interim financial statements/report – English.pdf Regulatory Filings	2020-09-25	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2020-06-27	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2020-06-27	English
Interim MD&A - English.pdf Regulatory Filings	2020-06-27	English
Interim financial statements/report – English.pdf Regulatory Filings	2020-06-27	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2020-03-27	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2020-03-27	English
Interim financial statements/report – English.pdf Regulatory Filings	2020-03-27	English
Interim MD&A - English.pdf Regulatory Filings	2020-03-27	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2020-02-28	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2020-02-28	English
Annual MD&A - English.pdf Regulatory Filings	2020-02-28	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2020-02-28	English
Audited annual financial statements – English.pdf Regulatory Filings	2020-02-28	English